$244,354
＋9.4%
SR Director, Process DEV and CELL Therapies
2024
$204k
50 hrs/wk
$41k
--
SR Director, Process DEV and CELL Therapies at Gencure
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Mari Lane Salmi has been listed as an employee of Gencure in Form 990 filings since fiscal year 2022. Total compensation for Mari Lane Salmi has increased by 40.7% from 2022 to 2024.